Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ZOM stock price vs ZBRA: inconclusive — current versus $0.10 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ZBRA's multiple
Implied fair value · at ZOM's multiple
Needs ZOM P/S.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ZOM FY 2025 (ended Dec 31, 2025) · ZBRA FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 87% equity / 13% debt · EV / Revenue 3.62x · EV / EBITDA 22.36x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Zomedica Corp. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Zebra Technologies Corporation · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.04x
0.70x
Net debt / EBITDA
Leverage against operating earnings
0.06x
2.72x
Cash and equivalents
Liquid reserves on the balance sheet
$9.02M
$125.00M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Zoetis Inc.
ZOM vs ZTS
Elanco Animal Health Inc
ZOM vs ELAN
PHIBRO ANIMAL HEALTH CORP
ZOM vs PAHC
NEXTERA ENERGY INC
ZOM vs NEE
COGNEX CORP
ZOM vs CGNX
Walgreens Boots Alliance, Inc.
ZOM vs WBA
Avery Dennison Corp
ZOM vs AVY
Leidos Holdings, Inc.
ZOM vs LDOS
MICRON TECHNOLOGY INC
ZOM vs MU
$4.36M
$2.50B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
